Vietnam-based Thanh Nam Long Company Joins Philux Global Group, Inc. (a/k/a PHI Group, Inc.) to launch Luxembourg-based infrastructure fund for Vietnam
February 07, 2023 08:45 ET
|
PHI Group, Inc.
New York, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Philux Global Group, Inc. (a/k/a PHI Group, Inc.; www.philuxglobal.com, PHIL), announced today that Thanh Nam Long Co., Ltd., a Vietnamese construction...
PHI GROUP INC (N/KA PHILUX GLOBAL GROUP) UPDATES ON ASIA DIAMOND EXCHANGE PROJECT IN VIETNAM
February 01, 2023 14:52 ET
|
PHI Group, Inc.
New York, Feb. 01, 2023 (GLOBE NEWSWIRE) -- PHI Group, Inc. (n/k/a Philux Global Group Inc.,www.philuxglobal.com, PHIL), a diversified holding company currently sponsoring PHILUX Global Funds,...
SIGA Technologies Announces Planned Retirement of CEO Phil Gomez in 2023
January 17, 2023 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Phil...
Lava for Good’s ‘Wrongful Conviction with Maggie Freleng’ Podcast Returns for Season Two
January 09, 2023 13:31 ET
|
Lava for Good
NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Today, Lava for Good’s Wrongful Conviction with Maggie Freleng podcast returns for its powerful second season. Hosted by Pulitzer Prize winner, renowned...
Gen4 Welcomes Globally Recognized Cosmetic Dentist, Dr. Bill Dorfman
December 06, 2022 13:29 ET
|
Gen4 Dental Partners
Tempe, AZ, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Gen4 Dental Partners, a Thurston Group portfolio company, is proud to announce a new partner: Dr. Bill Dorfman, DDS, a top Hollywood cosmetic and general...
Emergex Generates Chikungunya Ligandome, a Milestone in the Development of its T cell Adaptive Vaccine
November 28, 2022 07:00 ET
|
Emergex Vaccines Holding Ltd
PRESS RELEASE Emergex Generates Chikungunya Ligandome, a Milestone in the Development of its T cell Adaptive Vaccine Peptides specific to Chikungunya (CHIKV) virus expressed on surfaces of infected...
Jeito Capital co-leads EUR 50 million financing in CatalYm, a clinical-stage biopharma company developing novel immunotherapies for patients with cancer
November 22, 2022 05:00 ET
|
Jeito Capital
Jeito Capital co-leads EUR 50 million financing in CatalYm, a clinical-stage biopharma company developing novel immunotherapies for patients...
Jeito Capital investit dans CatalYm Jeito Capital investit dans CatalYm société biopharmaceutique allemande spécialisée en immuno-oncologie
November 22, 2022 05:00 ET
|
Jeito Capital
Jeito Capital investit dans CatalYm société biopharmaceutique allemande spécialisée en immuno-oncologie Jeito Capital co-dirige un financement de série C de 50 millions d'euros avec Brandon...
Healthy Extracts Introduces New Video Series Hosted by Fitness & Nutrition Expert, Whitney Johns, and America’s Healthy Heart Doc, Joel Kahn
November 03, 2022 08:31 ET
|
Healthy Extracts Inc.
LAS VEGAS, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, has launched a new...
SIGA Technologies to Host Business Update Call on November 3rd, 2022 Following Release of Third Quarter 2022 Financial Results
October 27, 2022 16:15 ET
|
SIGA Technologies Inc.
NEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...